Bioceres Crop Solutions (BIOX) Projected to Post Earnings on Thursday

Bioceres Crop Solutions (NASDAQ:BIOX) is expected to issue its Q1 2027 resultson Thursday, November 12th. Analysts expect Bioceres Crop Solutions to post earnings of $0.02 per share for the quarter. Investors are encouraged to explore the company’s upcoming Q1 2027 earnings results page for the latest details on the call scheduled for Thursday, November 19, 2026 at 8:30 AM ET.

Bioceres Crop Solutions (NASDAQ:BIOX) last issued its quarterly earnings data on Tuesday, September 15th. The company reported ($0.39) EPS for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.33). Bioceres Crop Solutions had a negative return on equity of 39.11% and a negative net margin of 94.76%. The company had revenue of $55.90 million for the quarter, compared to analyst estimates of $79.00 million.

Bioceres Crop Solutions Trading Up 1.4%

Shares of NASDAQ BIOX opened at $0.24 on Tuesday. Bioceres Crop Solutions has a 1-year low of $0.19 and a 1-year high of $2.03. The business has a 50-day moving average of $0.33 and a 200-day moving average of $0.45. The company has a quick ratio of 0.63, a current ratio of 0.81 and a debt-to-equity ratio of 0.94.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Bioceres Crop Solutions in a report on Friday, October 9th. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Bioceres Crop Solutions has a consensus rating of “Reduce” and an average target price of $2.00.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp. is an Argentina-based agricultural biotechnology company focused on developing technologies that improve crop productivity, resilience and sustainability. The company serves farmers and agricultural businesses through products designed to support crop establishment, nutrition, protection and performance under challenging environmental conditions.

Its portfolio includes the HB4 biotechnology platform, which is used in drought-tolerant wheat and soybean varieties, as well as biological seed treatments, microbial inoculants, biofertilizers, biostimulants and biological crop-protection products.